Sahil Kirpekar

All filings by Sahil Kirpekar on record concern ATAI Life Sciences N.V. The record holds 4 filings, for trades running from 14 March 2024 to 21 March 2025.

Sales make up the whole of the open-market record (2 sales, €122k). Besides market trades, the filings include 2 option exercises. Since January 2025: no purchases and 1 sale on the market.

Most recently, on 24 March 2025, the filings show an open-market sale worth €60k in ATAI Life Sciences N.V. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.